Adderall Recall 2025 Interactive Map. Adderall Shortages Push ADHD Patients to Make Adjustments WSJ Food and Drug Administration (FDA) announced that pharmaceutical manufacturer Lannet Company issued a voluntary, nationwide recall of one particular generic ADHD medication: Lisdexamfetamine dimesylate capsules. The 10 mg, 15 mg, and 30 mg immediate-release tablets are on back order and the company estimates a release date of late-1st quarter 2025.
Adderall users struggle amid ongoing medication shortage CNN from www.cnn.com
Also known by the brand name Strattera and only available via prescription, atomoxetine may be prescribed to treat children, teenagers, and adults with attention-deficit hyperactivity disorder (ADHD). Find local businesses, view maps and get driving directions in Google Maps.
Use this page to search the Government of Canada database of recalls and safety alerts for consumer products, vehicles, food and health products ADHD medication recall: Potential side-effects of pill mix-up People who take carbinoxamine instead of Zenzedi will experience "undertreatment of their symptoms" the FDA reported, which may lead. Also known by the brand name Strattera and only available via prescription, atomoxetine may be prescribed to treat children, teenagers, and adults with attention-deficit hyperactivity disorder (ADHD).
Adderall Addiction Signs, Effects, Treatment, and Prevention. Food and Drug Administration (FDA) announced that pharmaceutical manufacturer Lannet Company issued a voluntary, nationwide recall of one particular generic ADHD medication: Lisdexamfetamine dimesylate capsules. People taking medications for ADHD, or attention-deficit hyperactivity disorder, may face disruptions in accessing treatment after the arrests of two executives of a telehealth company that.
Adderall shortage FDA confirms reports patients are struggling to fill. The drug maker said in a recent recall notice that it is. The 10 mg, 15 mg, and 30 mg immediate-release tablets are on back order and the company estimates a release date of late-1st quarter 2025.